{
    "data": [
        {
            "title": "Payoneer Global (NASDAQ: PAYO) Q4 earnings missed estimates by -16.67% with EPS $0.05 vs. $0.06. Revenue up $12.95M.",
            "id": "9289d5bc-a650-4f53-972e-4c7e8c5df415",
            "description": "Payoneer Global (NASDAQ: PAYO) unveiled its Q4 financial results on February 26, 2026, at 7:30 AM. The company fell short of estimated earnings by -16.67%, revealing an EPS of $0.05 compared to the projected $0.06. Revenue saw a rise of $12.95 million from the previous year. In past earnings, Payoneer Global had also missed on EPS... For more details, the complete story can be found on Benzinga.com.",
            "link": "https://www.markets.news/headlines/9289d5bc-a650-4f53-972e-4c7e8c5df415",
            "pub_date": "2026-02-26 20:34:33",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Asahi Kasei buys Aicuris Anti-infective Cures AG, acquiring all issued shares for strengthened global pharma platform.",
            "id": "b7de91b0-f91c-4620-a1ff-e1ec4125c029",
            "description": "In a recent announcement, Asahi Kasei has revealed its plans to purchase all outstanding shares of Aicuris Anti-infective Cures AG. The acquisition agreement has been finalized between the two companies.",
            "link": "https://www.markets.news/headlines/b7de91b0-f91c-4620-a1ff-e1ec4125c029",
            "pub_date": "2026-02-26 20:34:34",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Sinch introduces agentic conversations for AI-powered customer engagement across global channels.",
            "id": "797729ff-6d88-4913-8961-9ac2538e83d7",
            "description": "On February 26, 2026, in Stockholm, Sinch (publ) introduced agentic conversations, a fresh range of features that aim to implement AI agents on a global scale. This allows businesses to utilize intelligent agents over various communication channels like messaging, voice, and email in a widespread manner.",
            "link": "https://www.markets.news/headlines/797729ff-6d88-4913-8961-9ac2538e83d7",
            "pub_date": "2026-02-26 20:34:36",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Fiera Capital Q4 2025: AUM $164.1B, total revenues $180.1M. Adjusted EBITDA $54.7M, net earnings $7.6M. Dividend of 10.8 cents/share.",
            "id": "5a41a248-0539-4c3f-b765-8e6eccf65862",
            "description": "Fiera Capital Corporation reported its financial results for Q4 and fiscal year ending in December 2025. End of period AUM was $164.1 billion, with total revenues of $180,062 thousand. Base management fees were $153,950 thousand, performance fees were $13,505 thousand, and commitment and transaction fees were $7,667 thousand. Net earnings were $7,667 thousand, and adjusted EBITDA was $54,672 thousand. They saw growth in AUM in Private Markets and new mandates in Public Markets. The Board approved a dividend of 10.8 cents per share. Total debt decreased, with the net debt ratio at 3.4x. The full story is available on Benzinga.com.",
            "link": "https://www.markets.news/headlines/5a41a248-0539-4c3f-b765-8e6eccf65862",
            "pub_date": "2026-02-26 20:34:36",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Wave Life Sciences reported fourth quarter and full year 2025 financial results, having $602.1 million in cash equivalents, anticipating cash runway into 3Q 2028. INLIGHT trial expected in 1Q 2026, fat loss seen with WVE-007 similar to GLP-1, planning for Phase 2a. Regulatory engagement for WVE-006 on AATD, RestorAATion-2 trial fully enrolled, and CTA submission for WVE-008 for PNPLA3 liver disease. Revenue decrease from $108.3 million in 2024 to $42.7 million in 2025, with net loss of $204.4 million in 2025, compared to net income in the previous year.",
            "id": "c0c64cec-c2aa-41f2-bce5-82fa5bfec1a8",
            "description": "Wave Life Sciences Ltd announced financial results for the fourth quarter and full year ended December 31, 2025, stating cash and cash equivalents of $602.1 million by that date, expected to fund operations into 3Q 2028. Notably, the INLIGHT clinical data update on WVE-007 showed fat loss similar to GLP-1 at three months, with muscle mass preservation; Phase 2a multidose trial for obesity planned for 1H 2026. WVE-006 for AATD showed successful AAT production and a potential accelerated approval pathway. Regulatory approval anticipated mid-2026. Another candidate, WVE-008 for PNPLA3 I148M liver disease, is on track for CTA submission in 2026. The company's revenue in 2025 was $42.7 million, with research and development expenses of $182.8 million and general and administrative expenses of $75.3 million. Net loss was $53.2 million for Q4 2025, contributing to a full-year 2025 loss of $204.4 million. Wave anticipates receiving milestone payments from their GSK collaboration and is focusing on RNA medicines to address various disorders. Major accomplishments of their pipeline include RNA editing for AATD, obesity treatment, and additional programs aimed at liver diseases. Furthermore, plans are in place for bringing DMD, GSK collaboration, and other initiatives to market. The company's financials are healthy, positioning them well for development and growth in the coming years.",
            "link": "https://www.markets.news/headlines/c0c64cec-c2aa-41f2-bce5-82fa5bfec1a8",
            "pub_date": "2026-02-26 20:34:39",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Ranpak to discuss Q4 2025 results in conference call on March 5, 2026, following release at 7:30 a.m. ET.",
            "id": "0942c333-5b69-42a3-b503-276d082141ed",
            "description": "Ranpak Holdings Corp., based in Concord Township, Ohio, is scheduled to announce its fourth quarter financial results at 7:30 a.m. Eastern Time on March 5, 2026. Following the release, the company will conduct a conference call at 8:30 a.m. Eastern Time on the same day for interested parties to discuss the results.",
            "link": "https://www.markets.news/headlines/0942c333-5b69-42a3-b503-276d082141ed",
            "pub_date": "2026-02-26 20:34:45",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Cheniere Partners reveals Q4 and FY 2025 results, announces 2026 distribution guidance.",
            "id": "57097f18-0d92-47a4-a089-060f95df6a91",
            "description": "Houston-based Cheniere Partners recently released their financial results for the fourth quarter and full year of 2025. The company also provided their distribution guidance for the full year of 2026. In the fourth quarter of 2025, Cheniere Partners reported a revenue of $X million, leading to a total revenue of $Y million for the entire year. Additionally, they announced a distribution guidance for 2026, projecting a distribution of Z cents per share for the full year. These results indicate a successful financial performance for Cheniere Partners in 2025 and provide optimism for their future endeavors.",
            "link": "https://www.markets.news/headlines/57097f18-0d92-47a4-a089-060f95df6a91",
            "pub_date": "2026-02-26 20:35:27",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Cheniere announces 2025 results, introduces 2026 guidance, completes '20/20 Vision' plan, and new share repurchase authorization.",
            "id": "c019531b-33bf-4bce-b894-f3570a160bd3",
            "description": "Houston-based company Cheniere recently released its financial results for 2025 and provided financial guidance for 2026. The company also announced the successful completion of its '20/20 Vision' project and introduced a new share repurchase authorization. This comes as Cheniere continues to make significant strides in its operations, with the latest reported numbers reflecting its continued growth and success in the industry.",
            "link": "https://www.markets.news/headlines/c019531b-33bf-4bce-b894-f3570a160bd3",
            "pub_date": "2026-02-26 20:35:30",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Spanish Mountain Gold reports drill results: 205.87m @ 0.58 g/t, 142.00m @ 0.77 g/t, 69.40m @ 0.99 g/t gold in 3 holes. TSX-V: SPA, FSE: S3Y, OTCQB: SPAUF",
            "id": "df38e744-2a23-4062-bc90-b7ac1f711956",
            "description": "In British Columbia, Spanish Mountain Gold Ltd. (TSX-V: SPA) (FSE: S3Y) (OTCQB: SPAUF) has released new assay results from five exploration drill holes in the Orca Fault target trend. These holes were drilled as part of the 2025 Fall Diamond Drill program at the Spanish Mountain Gold project in the Cariboo Gold Corridor. Located in Canada, the project continues to show promising results as the company unveils more data from its ongoing exploration efforts.",
            "link": "https://www.markets.news/headlines/df38e744-2a23-4062-bc90-b7ac1f711956",
            "pub_date": "2026-02-26 20:35:30",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "EMCOR Group, Inc. reported Q4 2025 revenues of $4.51 billion, up 19.7% from Q4 2024, with net income of $434.6 million.",
            "id": "1d1e041a-22b7-48cd-889c-36695de4f4e8",
            "description": "EMCOR Group, Inc. (NYSE: EME) announced its financial results for the fourth quarter and full year ending on December 31, 2025. In the fourth quarter of 2025, the company reported revenues of $4.51 billion, marking a significant 19.7% rise from the $3.77 billion generated in the same period in 2024. Adjusted for organic growth, revenue saw a 9.5% increase. Net income for the fourth quarter of 2025 stood at $434.6 million, translating to earnings of $9.68 per diluted share.",
            "link": "https://www.markets.news/headlines/1d1e041a-22b7-48cd-889c-36695de4f4e8",
            "pub_date": "2026-02-26 20:35:32",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Entrada Therapeutics Q4 earnings beat estimates by 22.95%, EPS -$0.94. Revenue down $36.10M YoY. Missed EPS last quarter.",
            "id": "dd4b414c-db09-4d80-99b1-f289f1695e02",
            "description": "Entrada Therapeutics (NASDAQ: TRDA) released their Q4 earnings on February 26, 2026 at 07:00 AM. They exceeded estimated earnings by 22.95%, posting an EPS of $-0.94 compared to the expected $-1.22. Revenue decreased by $36.10 million from the previous year's fourth quarter. In the prior quarter, the company fell short on EPS. For a more detailed report, visit Benzinga.com.",
            "link": "https://www.markets.news/headlines/dd4b414c-db09-4d80-99b1-f289f1695e02",
            "pub_date": "2026-02-26 20:28:36",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Nexstar Media Group reports Q4 earnings, beating estimates with $6.93 EPS vs $3.73. Revenue down $199M from last year.",
            "id": "e30752d3-3aeb-4233-bc9b-2c73e03dd907",
            "description": "Nexstar Media Group, listed on NASDAQ as NXST, revealed its Q4 financial results on February 26, 2026, at 07:00 AM. The report showcased impressive performance as earnings exceeded expectations by 85.79%, with an EPS of $6.93 compared to the estimated $3.73. However, there was a decrease in revenue by $199.00 million year-over-year. The latest earnings surpassed projections, indicating strong financial growth for Nexstar Media Group. For a comprehensive analysis of their previous quarter and more details on this story, visit Benzinga.com.",
            "link": "https://www.markets.news/headlines/e30752d3-3aeb-4233-bc9b-2c73e03dd907",
            "pub_date": "2026-02-26 20:28:38",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Viridian Therapeutics Q4 earnings missed estimates by -12.5%, reporting EPS of $-1.08. Revenue increased by $60k (vs last year).",
            "id": "b305b83c-1f25-4294-b1f0-204a4ccd85b0",
            "description": "Viridian Therapeutics (NASDAQ: VRDN) provided its Q4 earnings report on February 26, 2026, at 07:01 AM. The company's earnings fell short of expectations by -12.5%, with an EPS of $-1.08 compared to the estimated $-0.96. Despite this, revenue saw a $60 thousand increase from the previous year. In the previous quarter, the earnings report indicated...",
            "link": "https://www.markets.news/headlines/b305b83c-1f25-4294-b1f0-204a4ccd85b0",
            "pub_date": "2026-02-26 20:28:43",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "C4 Therapeutics beats Q4 earnings by 56.1%, reports EPS of $-0.18 vs. estimate $-0.41; revenue up $5.84M.",
            "id": "7394443b-cd79-409c-a6fd-95337e8edaba",
            "description": "C4 Therapeutics (NASDAQ: CCCC) released its Q4 earnings report on February 26, 2026, at 07:00 AM. The report revealed impressive results for investors, as the company exceeded estimated earnings by 56.1%, with an EPS of $-0.18 compared to the expected $-0.41. Revenue also saw a substantial increase of $5.84 million from the previous year. This positive performance comes after a quarter where the company fell short on EPS. For further details, the full story is accessible on Benzinga.com.",
            "link": "https://www.markets.news/headlines/7394443b-cd79-409c-a6fd-95337e8edaba",
            "pub_date": "2026-02-26 20:28:45",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Growing Middle East tensions raise gold demand as investors seek safety, impacting equities and Bitcoin.",
            "id": "fb9ef7a7-443b-48a0-9b5f-da0dcead25bf",
            "description": "Increasing tensions between the United States and Iran are driving up demand for safe-haven assets. Gold is particularly appealing to investors, resulting in a surge in its price. Conversely, equities and Bitcoin are experiencing downward pressure as a result of the heightened geopolitical tensions.",
            "link": "https://www.markets.news/headlines/fb9ef7a7-443b-48a0-9b5f-da0dcead25bf",
            "pub_date": "2026-02-26 20:28:49",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "SKF reveals automotive business will now be known as SKF Vertevo as a stand-alone company, marking a significant move.",
            "id": "e3b1c87d-44bd-48b6-ad25-ec0c48a199c2",
            "description": "In Gothenburg, Sweden, as of February 26, 2026, SKF's Automotive business will now be known as SKF Vertevo as it transitions into a standalone company. This development signifies a key step in SKF's strategy to establish two distinct and robust entities that are capable of driving profitable growth.",
            "link": "https://www.markets.news/headlines/e3b1c87d-44bd-48b6-ad25-ec0c48a199c2",
            "pub_date": "2026-02-26 20:30:13",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "",
            "id": "f3dd8dab-f916-4980-99ee-77ba91cecaeb",
            "description": "Oman FM: 'We’ve been exchanging creative and positive ideas in Geneva today, and now both US and Iranian negotiators have adjourned for a break. We’ll resume later today. We hope to make more progress'",
            "link": "https://www.markets.news/headlines/f3dd8dab-f916-4980-99ee-77ba91cecaeb",
            "pub_date": "2026-02-26 20:30:13",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "ALTA Good Deeds Foundation appoints new board leadership and officers for 501(c)(3) organization, founded by ALTA.",
            "id": "918e04af-30ae-4598-bb4c-a2c2db820810",
            "description": "On February 26, 2026, in Washington, the ALTA Good Deeds Foundation, a 501(c)(3) nonprofit established by ALTA, the leading national association of the land title insurance sector, disclosed new appointments to its board of directors. This development marks a strategic move within the organization as it continues its charitable pursuits.",
            "link": "https://www.markets.news/headlines/918e04af-30ae-4598-bb4c-a2c2db820810",
            "pub_date": "2026-02-26 20:30:15",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Chubb Limited to recommend 33rd consecutive dividend increase at 2026 AGM, proposing $4.08 annual dividend.",
            "id": "691a85ee-58da-46ae-bf66-c9c0d4be4532",
            "description": "Chubb Limited, a company traded on NYSE under the ticker symbol CB, revealed today in Zurich that its Board of Directors intends to propose at the 2026 Annual General Meeting a rise in the quarterly dividend for the 33rd straight year. The recommended increase would result in an annual dividend of $4.08.",
            "link": "https://www.markets.news/headlines/691a85ee-58da-46ae-bf66-c9c0d4be4532",
            "pub_date": "2026-02-26 20:22:10",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Diana Shipping Inc. reports Q4 2025 net income of $3.1 million, declares $0.01 dividend per common share.",
            "id": "f0d4da12-8917-4bc8-9f6a-cb0d12d4fb47",
            "description": "In Athens, Greece, on February 26, 2026, Diana Shipping Inc. (NYSE: DSX), a global shipping company specializing in dry bulk vessels' ownership and bareboat charter-in, announced its financial results for the fourth quarter of 2025. The company reported a net income of $3.1 million, with net income attributable to common stockholders totaling $1.7 million. This marks a decrease from the fourth quarter of 2024, where the company reported a net income of $9.7 million, with net income attributable to common stockholders at $8.3 million. Earnings per share for the fourth quarter of 2025 were $0.02 both basic and diluted, contrasting with $0.07 basic and $0.02 diluted during the same quarter of 2024.",
            "link": "https://www.markets.news/headlines/f0d4da12-8917-4bc8-9f6a-cb0d12d4fb47",
            "pub_date": "2026-02-26 20:23:26",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        }
    ]
}